These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 26333844)

  • 41. Isoagglutinin adsorption in ABO-incompatible transplantation.
    Genberg H; Kumlien G; Wennberg L; Tydén G
    Transfus Apher Sci; 2010 Oct; 43(2):231-5. PubMed ID: 20667787
    [TBL] [Abstract][Full Text] [Related]  

  • 42. ABO-incompatible live donor renal transplantation using blood group A/B carbohydrate antigen immunoadsorption and anti-CD20 antibody treatment.
    Nordén G; Briggs D; Cockwell P; Lipkin G; Mjörnstedt L; Mölne J; Ready A; Rydberg L; Samuelsson O; Svalander CT; Breimer ME
    Xenotransplantation; 2006 Mar; 13(2):148-53. PubMed ID: 16623810
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Neither pre-transplant rituximab nor splenectomy affects de novo HLA antibody production after renal transplantation.
    Ashimine S; Watarai Y; Yamamoto T; Hiramitsu T; Tsujita M; Nanmoku K; Goto N; Takeda A; Katayama A; Uchida K; Kobayashi T
    Kidney Int; 2014 Feb; 85(2):425-30. PubMed ID: 23945498
    [TBL] [Abstract][Full Text] [Related]  

  • 44. ABO-incompatible kidney transplantation.
    Schousboe K; Titlestad K; Baudier F; Hansen LU; Bistrup C
    Dan Med Bull; 2010 Oct; 57(10):A4197. PubMed ID: 21040684
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Once-daily vs twice-daily tacrolimus for de novo living kidney transplantation patients including ABO/HLA compatible and incompatible: A randomized trial.
    Okumi M; Unagami K; Furusawa M; Kakuta Y; IIzuka J; Takagi T; Shirakawa H; Shimizu T; Omoto K; Inui M; Ishida H; Tanabe K
    Clin Transplant; 2018 Dec; 32(12):e13423. PubMed ID: 30318624
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Outcome of desensitization in human leukocyte antigen- and ABO-incompatible living donor kidney transplantation: a single-center experience in more than 100 patients.
    Al Meshari K; Pall A; Chaballout A; El Gamal H; Al Mana H; Humaidan H; Alzayer F; Al Talhi M
    Transplant Proc; 2013 May; 45(4):1423-6. PubMed ID: 23726587
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effect of rituximab dose on infectious complications in ABO-incompatible kidney transplantation.
    Lee J; Lee JG; Kim S; Song SH; Kim BS; Kim HO; Kim MS; Kim SI; Kim YS; Huh KH
    Nephrol Dial Transplant; 2016 Jun; 31(6):1013-21. PubMed ID: 27190360
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Postoperative rebound of antiblood type antibodies and antibody-mediated rejection after ABO-incompatible living-related kidney transplantation.
    Ishida H; Kondo T; Shimizu T; Nozaki T; Tanabe K
    Transpl Int; 2015 Mar; 28(3):286-96. PubMed ID: 25363583
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Biliary stricture is the only concern in ABO-incompatible adult living donor liver transplantation in the rituximab era.
    Song GW; Lee SG; Hwang S; Kim KH; Ahn CS; Moon DB; Ha TY; Jung DH; Park GC; Kang SH; Jung BH; Yoon YI; Kim N
    J Hepatol; 2014 Sep; 61(3):575-82. PubMed ID: 24801413
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long-term Follow-up of ABO-Incompatible Kidney Transplantation in Freiburg, Germany: A Single-Center Outcome Report.
    Langhorst C; Ganner A; Schneider J; Prager EP; Walz G; Pisarski P; Jänigen B; Zschiedrich S
    Transplant Proc; 2021 Apr; 53(3):848-855. PubMed ID: 33041078
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bleeding complications in pediatric ABO-incompatible kidney transplantation.
    Schaefer B; Tönshoff B; Schmidt J; Golriz M; Mehrabi A; Gombos P; Morath C; Wühl E; Schaefer F; Schmitt CP
    Pediatr Nephrol; 2013 Feb; 28(2):327-32. PubMed ID: 22961637
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immune Desensitization Allows Pediatric Blood Group Incompatible Kidney Transplantation.
    Stojanovic J; Adamusiak A; Kessaris N; Chandak P; Ahmed Z; Sebire NJ; Walsh G; Jones HE; Marks SD; Mamode N
    Transplantation; 2017 Jun; 101(6):1242-1246. PubMed ID: 27463537
    [TBL] [Abstract][Full Text] [Related]  

  • 53. ABO-incompatible kidney transplantation using antigen-specific immunoadsorption and rituximab: a 3-year follow-up.
    Genberg H; Kumlien G; Wennberg L; Berg U; Tydén G
    Transplantation; 2008 Jun; 85(12):1745-54. PubMed ID: 18580466
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The utilization and advantages of an exchange donor program in living donor renal transplantation: a single-center experience.
    Kim HS; Kwon OJ; Kang CM
    Transplant Proc; 2012 Jan; 44(1):14-6. PubMed ID: 22310566
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Everolimus-based, calcineurin-inhibitor-free regimen in recipients of de-novo kidney transplants: an open-label, randomised, controlled trial.
    Budde K; Becker T; Arns W; Sommerer C; Reinke P; Eisenberger U; Kramer S; Fischer W; Gschaidmeier H; Pietruck F;
    Lancet; 2011 Mar; 377(9768):837-47. PubMed ID: 21334736
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Outcomes Following ABO-Incompatible Kidney Transplantation Performed After Desensitization by Nonantigen-Specific Immunoadsorption.
    Becker LE; Siebert D; Süsal C; Opelz G; Leo A; Waldherr R; Macher-Goeppinger S; Schemmer P; Schaefer SM; Klein K; Beimler J; Zeier M; Schwenger V; Morath C
    Transplantation; 2015 Nov; 99(11):2364-71. PubMed ID: 25989497
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Outcome of ABO-Incompatible Living Donor Renal Transplantations: A Single-Center Experience From Eastern India.
    Ray DS; Thukral S
    Transplant Proc; 2016 Oct; 48(8):2622-2628. PubMed ID: 27788792
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Findings of graft biopsy specimens within 90 days after ABO blood group incompatible living donor kidney transplantation compared with ABO-identical and non-identical transplantation.
    Ushigome H; Okamoto M; Koshino K; Nobori S; Okajima H; Masuzawa N; Urasaki K; Yoshimura N
    Clin Transplant; 2010 Jul; 24 Suppl 22():16-21. PubMed ID: 20590688
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Successful launch of an ABO-incompatible kidney transplantation program to overcome the shortage of compatible living donors: experience at a single center
.
    Song SH; Lee J; Kim BS; Kim S; Lee JG; Jeong HJ; Kim YS; Kim MS; Kim HO; Kim SI; Huh KH
    Clin Nephrol; 2017 Sep; 88(9):117-123. PubMed ID: 28679466
    [TBL] [Abstract][Full Text] [Related]  

  • 60. ABO blood group incompatible renal transplantation in New Zealand: a report of the first 20 cases.
    Ho E; Yasutomi M; Gounder D; Dittmer I
    N Z Med J; 2016 Jan; 129(1429):45-9. PubMed ID: 26914298
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.